ARP238P-12
[Polyclonal Antibody]
Phospho-ALK-Tyr1586 Rabbit Polyclonal Antibody
www.yhsbio.com
market@yhsbio.com
support@yhsbio.com
+86-21-54651191
Room 703,Building 6,333# Guiping
Rd.,Xuhui District,Shanghai,China
DATASHEET
Species: |
Rabbit |
Applications: |
IHC |
Immunogen Range: |
A synthetic phosphopeptide corresponding to residues surrounding Y1586 of ALK |
Clonality: |
Polyclonal Antibody |
Isotype: |
/ |
GENE ID: |
238 |
Swiss Prot: |
Q9UM73 |
Synonyms: |
CD246, Ki-1, TFG/ALK |
Purification: |
Ammonium sulfate precipitation |
Storage: |
Store at 4°C. For long term storage store at -20°C in PBS, pH 7.2 (0.05% sodium azide).Avoid freeze/thaw cycles. |
Background: |
Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor for pleiotrophin (PTN), a growth factor involved in embryonic brain development (1-3). In ALK-expressing cells, PTN induces phosphorylation of both ALK and the downstream effectors IRS-1, Shc, PLCγ, and PI3 kinase (1). ALK was originally discovered as a nucleophosmin (NPM)-ALK fusion protein produced by a translocation (4). Investigators have found that the NPM-ALK fusion protein is a constitutively active, oncogenic tyrosine kinase associated with anaplastic lymphoma (4). Research literature suggests that activation of PLCγ by NPM-ALK may be a crucial step for its mitogenic activity and involved in the pathogenesis of anaplastic lymphomas (5).A distinct ALK oncogenic fusion protein involving ALK and echinoderm microtubule-associated protein like 4 (EML4) has been described in the research literature from a non-small cell lung cancer (NSCLC) cell line, with corresponding fusion transcripts present in some cases of lung adenocarcinoma. The short, amino-terminal region of the microtubule-associated protein EML4 is fused to the kinase domain of ALK (6-8). |
Caculated MW: |
80-220 kDa |
Observed MW: |
Refer to Figures |
Applications: |
IHC 1:50-1:200
|
Reacitivity: |
Human |
For research use only. Not intended for diagnostic or therapeutic use!